SONORIS
ActiveSummary
SONORIS has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €38,970 and a net result of -€2,852. Equity is growing by ~29.8% per year across the filed fiscal years. Its solvency ranks better than 52% of 17112 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
What stands out
Overview
0 of 1 deed readAccounts 13 d earlyTurnover not published (abridged schema)
Why 71- Limited track record- Annual accounts: weaker financial profile+ Lower-failure-rate sectorLatest accounts filed on timeShow the evidence
Checked score
Score 2025
Axes · tick = 2024
Profitability13▼-83
Solvency91▲+8
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2,500 at 30 days acceptable
Liquidity ample (current ratio 3.35 against 1.7 in 2024; short-term debt: 29.2% and cash: 86.7% of total assets), and 34.4% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
65.6%
Return on assets
-4.8%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-07-2026, 13 days ahead of the deadline.
NBB · 5 filingsDeviation from the deadline
2025
13 d early
2024
13 d early
2023
5 d early
2022
11 d early
2021
2 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 5 accounts on average 9 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 20 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
01-10-2026 today31-12-2026 close31-07-2027 deadline
- Annual accounts filedfiscal year 2025 · micro…
- Annual accounts filedfiscal year 2024 · micro…
- Annual accounts filedfiscal year 2023 · micro…
Financials
Fiscal year 2025Total assets €59,366Loss -€2,852Solvency 65.6%Liquidity 3.35
Total assets
€59,366▼ 17.4%
2021 - 2025
Net result
-€2,852
2021 - 2025
Equity
€38,970▼ 6.8%
2021 - 2025
Solvency
65.6%▲ 7.4pp
2021 - 2025
Financials · fiscal year 2025, micro schema
Trend over the years
Trend over the years
In euros
In per cent
Ratio
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€16,301--€14,005€31,429€21,979▼ 30.1%-€2,199
Net result€12,605below the sector's middle half--€14,088below the sector's middle half€25,540within the sector's middle half€15,765below the sector's middle half▼ 38.3%-€2,852below the sector's middle half
Equity€14,605below the sector's middle half-€517below the sector's middle half▼ 96.5%€26,057below the sector's middle half▲ 4,940%€41,822below the sector's middle half▲ 60.5%€38,970within the sector's middle half▼ 6.8%
Total assets€21,931below the sector's middle half-€7,767below the sector's middle half▼ 64.6%€37,815below the sector's middle half▲ 387%€71,848below the sector's middle half▲ 90.0%€59,366below the sector's middle half▼ 17.4%
Debt€7,325-€7,250▼ 1.0%€11,758▲ 62.2%€30,026▲ 155%€20,396▼ 32.1%
Working capital€1,505below the sector's middle half--€2,106below the sector's middle half€24,243within the sector's middle half€15,409below the sector's middle half▼ 36.4%€40,676within the sector's middle half▲ 164%
Solvency66.6%within the sector's middle half-6.7%below the sector's middle half▼ 59.9pp68.9%within the sector's middle half▲ 62.3pp58.2%within the sector's middle half▼ 10.7pp65.6%within the sector's middle half▲ 7.4pp
Current ratio1.21below the sector's middle half-0.71below the sector's middle half▼ 0.503.06within the sector's middle half▲ 2.351.70within the sector's middle half▼ 1.363.35within the sector's middle half▲ 1.64
Return on assets (ROA)57.5%above the sector's middle half--181.4%below the sector's middle half▼ 238.9pp67.5%above the sector's middle half▲ 248.9pp21.9%within the sector's middle half▼ 45.6pp-4.8%below the sector's middle half▼ 26.7pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result and balance sheet
Result per fiscal year
Operating resultNet result
The operating result turns negative in 2025: a loss of €2,199 after €21,979 in 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €59,366
Fixed assets
€1,356 ▼ 96.1%
Current assets
€58,010 ▲ 55.6%
Equity and liabilities €59,366
Equity
€38,970 ▼ 6.8%
Debt
€20,396 ▼ 32.1%
Debt's share of the balance-sheet total falls from 41.8% to 34.4%. Equity and debt are lower.
Key figures and ratios
Key figures and ratios
EBITDA
-€1,151▼
2024 · €25,185
Cash flow
-€1,804▼
2024 · €18,972
Debt to equity
0.52▼
2024 · 0.72
ROE
-7.3%▼
2024 · 37.7%
Interest coverage
-1.76▼
2024 · 63.24
Debt ≤ 1 year
€17,334▼
2024 · €21,882
Debt > 1 year
€3,061▼
2024 · €8,144
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 3,441 companies that looked in July 2024 the way this one looks now, 2.3% went bankrupt within 24 months and 90% are still going.
- Micro
- 5 to 10 years old
- solvency 30% or more
- a small loss
2.3%
went bankrupt
7.5%
stopped otherwise
90%
still going
A further 0.2% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 3,441 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Filed annual accounts
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €950 | €810 | €810 | €3,207 | €1,048 | ▼ 67.3% |
| Other operating charges640/8 | €695 | €937 | €1,495 | €4,041 | €18,168 | ▲ 350% |
| Non-recurring operating charges66A | - | €7,247 | - | - | - | - |
| Gross operating margin9900 | €17,946 | -€5,012 | €33,735 | €29,227 | €17,017 | ▼ 41.8% |
| Operating profit (loss)9901 | €16,301 | -€14,005 | €31,429 | €21,979 | -€2,199 | ▼ 110% |
| Financial charges65/66B | €4 | €83 | €46 | €398 | €653 | ▲ 64.0% |
| Recurring financial charges65 | €4 | €83 | €46 | €398 | €653 | ▲ 64.0% |
| Profit (loss) for the period before taxes9903 | €16,298 | -€14,088 | €31,383 | €21,581 | -€2,852 | ▼ 113% |
| Income taxes67/77 | €3,692 | - | €5,843 | €5,815 | - | - |
| Profit (loss) for the period9904 | €12,605 | -€14,088 | €25,540 | €15,765 | -€2,852 | ▼ 118% |
| Profit (loss) for the period to be appropriated9905 | €12,605 | -€14,088 | €25,540 | €15,765 | -€2,852 | ▼ 118% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €21,931 | €7,767 | €37,815 | €71,848 | €59,366 | ▼ 17.4% |
| Formation expenses20 | €920 | €690 | €460 | €230 | - | - |
| Fixed assets21/28 | €12,180 | €1,933 | €1,353 | €34,327 | €1,356 | ▼ 96.1% |
| Tangible fixed assets22/27 | €12,180 | €1,933 | €1,353 | €34,327 | €1,356 | ▼ 96.1% |
| Plant, machinery and equipment23 | - | - | - | - | €1,162 | - |
| Furniture and vehicles24 | €12,180 | €1,933 | €1,353 | €34,327 | €193 | ▼ 99.4% |
| Current assets29/58 | €8,831 | €5,143 | €36,001 | €37,291 | €58,010 | ▲ 55.6% |
| Amounts receivable within one year40/41 | €445 | €3,760 | - | €4,439 | €6,526 | ▲ 47.0% |
| Trade receivables40 | - | €3,315 | - | - | - | - |
| Other amounts receivable41 | €445 | €445 | - | €4,439 | €6,526 | ▲ 47.0% |
| Cash at bank and in hand54/58 | €8,386 | €1,384 | €36,001 | €32,852 | €51,484 | ▲ 56.7% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €21,931 | €7,767 | €37,815 | €71,848 | €59,366 | ▼ 17.4% |
| Equity10/15 | €14,605 | €517 | €26,057 | €41,822 | €38,970 | ▼ 6.8% |
| Contributions10/11 | €2,000 | €2,000 | €2,000 | €2,000 | €2,000 | = |
| Profit (loss) carried forward14 | €12,605 | -€1,483 | €24,057 | €39,822 | €36,970 | ▼ 7.2% |
| Amounts payable17/49 | €7,325 | €7,250 | €11,758 | €30,026 | €20,396 | ▼ 32.1% |
| Amounts payable after more than one year17 | - | - | - | €8,144 | €3,061 | ▼ 62.4% |
| Financial debts170/4 | - | - | - | €8,144 | €3,061 | ▼ 62.4% |
| Amounts payable within one year42/48 | €7,325 | €7,250 | €11,758 | €21,882 | €17,334 | ▼ 20.8% |
| Current portion of amounts payable after more than one year42 | - | - | - | €4,881 | €5,082 | ▲ 4.1% |
| Trade debts44 | €1,028 | €557 | €125 | - | €236 | - |
| Suppliers440/4 | €1,028 | €557 | €125 | - | €236 | - |
| Taxes, remuneration and social security45 | €6,192 | €6,692 | €11,633 | €17,002 | €12,016 | ▼ 29.3% |
| Taxes450/3 | €6,192 | €6,692 | €11,633 | €17,002 | €12,016 | ▼ 29.3% |
| Other amounts payable47/48 | €105 | - | - | - | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €12,605 | -€14,088 | €25,540 | €15,765 | -€2,852 | ▼ 118% |
| + Depreciation and write-downs630 | €950 | €810 | €810 | €3,207 | €1,048 | ▼ 67.3% |
| Operating cash flow (approximation) | €13,555 | -€13,278 | €26,350 | €18,972 | -€1,804 | ▼ 110% |
| Investment in fixed assets (approximation) | - | €9,437 | -€230 | -€36,180 | €31,923 | ▲ 188% |
| Change in cash | - | -€7,002 | €34,618 | -€3,149 | €18,632 | ▲ 692% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Comparable companies
Similar companies · same sector, comparable size
IDG DENTAL
BE 0779.746.970
Lierde · Eq €38,971
SALVAGO
BE 1004.835.470
La Louvière · Eq €39,200
CONSCIENTA
BE 0654.751.978
Mechelen · Eq €38,492
w8control
BE 0661.609.086
Turnhout · Eq €39,491
AUDIVISION
BE 1008.609.562
Sint-Agatha-Berchem · Eq €39,542
Of 10,428 companies in this sector we hold annual accounts for 885. 651 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Timeline
8 eventsLatest 18-07-2026Next filing 31-07-2027
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
18-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
18-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
26-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Back to profitnet €25,540
Net result €25,540 after one loss-making year.
31-12
Financial
Liquidity quadruplescurrent ratio 3.06
Current ratio from 0.71 to 3.06.
20-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Weakest financial yearnet -€14,088
Net result drops to -€14,088, the lowest in the series; recovery starts the following year.
29-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Company details
Private limited company · founded 06-07-2020Year ends 31-12Peppol reachable1 site
Register details
Identification
Legal formPrivate limited company
Founded06-07-2020
Fiscal year end31-12
Activities, NACEBEL 2025
86995Nutrition and dietetics services
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
47789Other retail sale of new goods
E-invoicing
Reachable via Peppol
Peppol ID
0208:0749830091
Also
9925:BE0749830091
Registered
02-12-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 1 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Sites & property
Location & real-estate footprint
Registered office, Dilbeek · 1 establishment unit since 2020
Ground area
879 m²
Building footprint
290 m²
Volume, LiDAR
3,278 m³
Parcel 23016D0214/00Z003, Flanders · tallest building 14.8 m, ±4 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
SONORIS
since 2020unit no. 2.304.535.502
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23016D0214/00Z003 | Flanders | 879 m² | 1 · 290 m² | 14.8 m · 4 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.